Submission Details
| 510(k) Number | K212431 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 04, 2021 |
| Decision Date | February 07, 2022 |
| Days to Decision | 187 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K212431 is an FDA 510(k) clearance for the Biomet Answer/Impact/Integral Distal Centralizer/Centering Sleeve, a Prosthesis, Hip, Femoral Component, Cemented, Metal (Class II — Special Controls, product code JDG), submitted by Biomet, Inc. (Warsaw, US). The FDA issued a Cleared decision on February 7, 2022, 187 days after receiving the submission on August 4, 2021. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3360.
| 510(k) Number | K212431 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 04, 2021 |
| Decision Date | February 07, 2022 |
| Days to Decision | 187 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | JDG — Prosthesis, Hip, Femoral Component, Cemented, Metal |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3360 |